Hirota Fujiki - Concepedia

Author

Hirota Fujiki

Saitama Cancer Center ORCID

Also Known As

Fujiki Hirota, H FUJIKI, H Fujiki, H. FUJIKI, H. Fujiki, HIROTA FUJIKI, Hirota FUJIKI, Hirota Fujiki, Hiroyuki Fujiki

390

Publications

17.8K

Citations

H-Index

175

Concepts

All Affiliations

Saitama Cancer Center National Cancer Research Institute National Cancer Centre Japan Tokushima Bunri University

About

Hirota Fujiki is an author at Saitama Cancer Center specializing in medicine, tumor biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	56	157	10.8K
2	Natural Sciences	27	42	2.2K
3	Engineering	6	6	190
4	Health Sciences	6	6	375
5	Education	1	1	102

Hirota Fujiki

222

Publications

14.6K

Citations

H-Index

Page 1

	Year	Citations
Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR Rie Nishiwaki‐Matsushima, Tetsuya Ohta, Shinji Nishiwaki, Journal of Cancer Research and Clinical Oncology Tumor BiologyHepatologyMedicineLiver PhysiologyHepatobiliary Tumor	1992	806
Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter. Masami Suganuma, Hirota Fujiki, Hiroko Suguri, Proceedings of the National Academy of Sciences Black SpongeOkadaic AcidMedicineCutaneous BiologyPharmacology	1988	599
[Chemoprevention of cancer]. Hirota Fujiki PubMed Chemoprevention StrategyOncogenic AgentMedicineTannic AcidTannic Acids	1986	527
Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice. Masaru Suganuma, Sachiko Okabe, Michael W. Marino, PubMed Tpa-treated Tnf-/- MiceImmunologyPathologyCell DeathImmunologic Mechanism	1999	303
Antitumor promoting activity of (−)‐epigallocatechin gallate, the main constituent of “Tannin” in green tea Shigeru Yoshizawa, Takahiko Horiuchi, Hirota Fujiki, Phytotherapy Research Chemoprevention StrategyPathologyCancer BiologyTumor BiologyMolecular Pharmacology	1987	291
Synergistic effects of (--)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Masashi Suganuma, Sachiko Okabe, Yasuko Kai, PubMed Tea PolyphenolsChemoprevention StrategyImmunologyCell DeathCancer Biology	1999	237
Tumor promoters block tyrosine-specific phosphorylation of the epidermal growth factor receptor. B Friedman, A. Raymond Frackelton, Alonzo H. Ross, Proceedings of the National Academy of Sciences Epidermal Growth FactorSignal TransductionSignaling PathwayMedicineReceptor Tyrosine Kinase	1984	218
Effect of (−)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines Shun’ichiro Taniguchi, Hirota Fujiki, Hiroaki Kobayashi, Cancer Letters Lung MetastasisChemoprevention StrategyMedicineGreen TeaPathology	1992	215
Green tea and cancer chemoprevention Masami Suganuma, Sachiko Okabe, Naoko Sueoka, Mutation research. Fundamental and molecular mechanisms of mutagenesis Chemoprevention StrategyMedicinePharmacologyCancer PreventionAnti-cancer Agent	1999	199
Green Tea Extracts for the Prevention of Metachronous Colorectal Adenomas: A Pilot Study Masahito Shimizu, Yasushi Fukutomi, Mitsuo Ninomiya, Cancer Epidemiology Biomarkers & Prevention	2008	199

Page 1